PROTOKINETIX, INCORPORATED

PKTX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2010 FY2009 FY2008 FY2007 FY2006 FY2005 FY2004 FY2003
Revenue $0
Cost of Revenue
Gross Profit
Gross Margin
Operating Expenses
Research & Development $161.5K
SG&A Expense $213.0K
Operating Income $-1.4M
Operating Margin
Interest Expense $24.0K
Pretax Income $-1.4M
Income Tax Expense
Net Income $-1.4M $-1.3M $-1.6M $-2.7M $-2.0M $-4.8M $-6.4M $-3.7M
Net Margin
EPS (Basic) $-0.02
EPS (Diluted) $-0.02
Shares Outstanding (Basic)
Shares Outstanding (Diluted) 75.5M
Dividends Per Share
← Newer Page 3 of 4 Older →